Daniel Rueda

Inhibition of glioma growth in vivo by selective activation of the CB(2) cannabinoid receptor.

Cristina Sánchez, Marı́a L. de Ceballos, Teresa Gómez del Pulgar et al. · PubMed · 2001 · 426 citations

Medicine, Oncology, Pharmacology +15

The proteolytic activity of the paracaspase MALT1 is key in T cell activation

Fabien Rebeaud, Stephan Hailfinger, Anita Posevitz‐Fejfár et al. · Nature Immunology · 2008 · 300 citations

Life Sciences, Immunology, Molecular Biology +14

The Endocannabinoid Anandamide Inhibits Neuronal Progenitor Cell Differentiation through Attenuation of the Rap1/B-Raf/ERK Pathway

Daniel Rueda, Beatriz Navarro, Alberto Martínez‐Serrano et al. · Journal of Biological Chemistry · 2002 · 256 citations · Full text

Life Sciences, Neuroscience, Pharmacology +15

The CB₁Cannabinoid Receptor Is Coupled to the Activation of c-Jun N-Terminal Kinase

Daniel Rueda, Ismael Galve‐Roperh, Amador Haro et al. · Molecular Pharmacology · 2000 · 195 citations

Medicine, Biochemistry, Pharmacology +16

Involvement of Sphingomyelin Hydrolysis and the Mitogen-Activated Protein Kinase Cascade in the Δ9-Tetrahydrocannabinol-Induced Stimulation of Glucose Metabolism in Primary Astrocytes

Cristina Sánchez, Ismael Galve‐Roperh, Daniel Rueda et al. · Molecular Pharmacology · 1998 · 192 citations

Life Sciences, Biochemistry, Pharmacology +17